EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing

Sophie von Brauchitsch, Denise Haslinger, Silvia Lindlar, Holger Thiele, Natalie Bernsen, Felix Zahnert iD, Philipp S Reif, Yunus Balcik, Ping Yee Billie Au, Colin B Josephson iD, Janine Altmüller, Adam Strzelczyk iD und 4 weitere

Epilepsia Open · 2023

DOI: 10.1002/epi4.12719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2023. Verfasst von Sophie von Brauchitsch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt…. Hauptthemen laut MEDLINE: Intellectual Disability, Epilepsy, Epilepsy, Generalized. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hessisches Ministerium für Wissenschaft und Kunst.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The phenotypic and genotypic spectrum of adult patients with epilepsy and intellectual disability (ID) is less clear than in children. We investigated an adult patient cohort to further elucidate this and inform the genetic testing approach.

Methods

Fifty‐two adult patients (30 male, 22 female) with epilepsy, at least mild ID and no known genetic or acquired cause were included and phenotyped. Variants identified through exome sequencing were evaluated using ACMG criteria. Identified variants were compared with commercially available gene panels. Cluster analysis of two features, age at seizure onset and age at ascertainment of cognitive deficits, was performed.

Results

Median age was 27 years (range 20‐57 years) with median seizure onset at 3 years and median ascertainment of cognitive deficits at 1 year. Likely pathogenic/pathogenic variants were identified in 16/52 patients (31%) including 14 (27%) single nucleotide variants and 2 (4%) copy number variants. Simulated yield of commercial gene panels varied between 13% in small (≤144 genes) and 27% in large panels (≥1478 genes). Cluster analysis (optimal number 3 clusters) identified a cluster with early seizure onset and early developmental delay (developmental and epileptic encephalopathy, n = 26), a cluster with early developmental delay but late seizure onset (ID with epilepsy, n = 16) and a third cluster with late ascertainment of cognitive deficits and variable seizure onset (n = 7). The smaller gene panels particularly missed the genes identified in the cluster with early ascertainment of cognitive deficits and later onset of epilepsy (0/4) as opposed to the cluster with developmental and epileptic encephalopathy (7/10). Significance Our data indicates that adult patients with epilepsy and ID represent a heterogeneous cohort that includes grown‐up patients with DEE but also patients with primary ID and later onset of epilepsy. To maximize diagnostic yield in this cohort either large gene panels or exome sequencing should be used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityEpilepsyEpilepsy, GeneralizedChildHumansAdultMaleFemaleYoung AdultMiddle AgedGenetic TestingSeizures

Stichwörter der Autor:innen

adultsdevelopmental and epileptic encephalopathyepilepsygenetic testinggeneticsintellectual disabilityphenotype

Autor:innen und Institutionen

  • Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.
  • Center for Personalized Translational Epilepsy Research (CePTER), Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Goethe University, Frankfurt am Main, Germany.
  • Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Epilepsy Center Hessen, Department of Neurology, Philipps University Marburg, Marburg, Germany.
  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Alberta, Calgary, Canada.

ORCID-Profile: Felix Zahnert, Colin B Josephson, Adam Strzelczyk, Felix Rosenow, Karl Martin Klein

Förderung

  • Hessisches Ministerium für Wissenschaft und Kunst

Zitieren

APA

von Brauchitsch, S., Haslinger, D., Lindlar, S., Thiele, H., Bernsen, N., Zahnert, F., Reif, P. S., Balcik, Y., Au, P. Y. B., Josephson, C. B., Altmüller, J., Strzelczyk, A., Knake, S., Rosenow, F., Chiocchetti, A., & Klein, K. M. (2023). The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing. Epilepsia Open. https://doi.org/10.1002/epi4.12719

Vancouver

von Brauchitsch S, Haslinger D, Lindlar S, Thiele H, Bernsen N, Zahnert F, et al. The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing. Epilepsia Open. 2023. doi:10.1002/epi4.12719

BibTeX
@article{vonBrauchitsch2023,
  author = {von Brauchitsch, Sophie and Haslinger, Denise and Lindlar, Silvia and Thiele, Holger and Bernsen, Natalie and Zahnert, Felix and Reif, Philipp S and Balcik, Yunus and Au, Ping Yee Billie and Josephson, Colin B and Altmüller, Janine and Strzelczyk, Adam and Knake, Susanne and Rosenow, Felix and Chiocchetti, Andreas and Klein, Karl Martin},
  title = {The phenotypic and genotypic spectrum of epilepsy and intellectual disability in adults: Implications for genetic testing},
  journal = {Epilepsia Open},
  year = {2023},
  doi = {10.1002/epi4.12719}
}
Kostenlos starten →